Back to top

The Zacks Analyst Blog Highlights: Facebook, Air Liquide and Intuitive Surgical

Read MoreHide Full Article

For Immediate Release

Chicago, IL – July 25, 2017 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Facebook (NASDAQ: (FB - Free Report) Free Report), Air Liquide (OTCMKTS: (AIQUY - Free Report) Free Report) and Intuitive Surgical ( NASDAQ: (ISRG - Free Report) Free Report) .

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Monday’s Analyst Blog:

Watch Out for the Three Stooges: Global Week Ahead

In the Global Week Ahead, pay attention to three U.S. catalysts.

Will summer traders regard these three events as the Three Musketeers, charging up the hill, adding confidence? Or will they amount to the Three Stooges -- and give up a stumble or two -- and thus create a more ragged tone?

When you are writing on stock markets just a couple miles from the old Columbia Pictures studio lot, where Larry, Moe & Curley got their first and biggest boost, you become a partisan. Only time will tell the tale well.

First off, this will be the biggest earnings week of the Q2 season. There’s plenty of room for a lousy report. But there are so many, it may get washed out quickly.

Second, on Wednesday, the latest FOMC statement hits the tape. Watch out for market-moving comments about recent weak inflation data.

Third and finally, traders close out the week with a Friday 1st estimate of U.S. Q2 GDP growth. If Q2 doesn’t beat up on Q1, that would be considered a stumble.

Here is your U.S. roadmap—

Over the coming week, earnings will play the most significant role in both U.S. and global equity markets. 184 S&P500 firms release Q2 earnings. This will be the single heaviest reporting week of the season.

Key names: Alphabet (formerly Google), Newmont Mining, McDonald’s, 3M, Eli Lilly, Caterpillar, GM, AT&T, Coca-Cola, Ford, State Street, Boeing, Facebook, Procter & Gamble, UPS, Mastercard, Intel, Amazon, Starbucks, Mattel, Merck, Xerox and American Airlines.

On Wednesday, consensus expects the Federal Open Market Committee (FOMC) not to change its Fed Funds target range. It rests at 1.25%.

July is a statement-only event. But will the press release show FOMC members have big concerns over recent soft inflation figures? Or will the majority reinforce a belief that it is transitory?

Out on Friday, the week saves the best (or worst…) for last. The first estimate of U.S. GDP growth in Q2 arrives at 8:30am ET.

The U.S. recorded just +1.4% y/y growth in Q1. Bloomberg’s consensus expects +2.6% in Q2.

We can consult the Fed ‘nowcast’ forecasting business, though it is getting a bit crowded these days. The St. Louis Fed has +2.5%, which matches the Atlanta Fed’s latest estimate at +2.5%. Both estimates are a notch above the NY Fed’s at +1.9%.

Outside the U.S., pay attention to Brazil--

Out on Wednesday, consensus is firm. Banco Central do Brasil will cut its SELIC policy rate by 100 basis points (bps) agajn. It would follow on a 100 bps cut on May 31st.

If that Brazilian cut happens, it would bring cumulative easing since last October to five full percentage points, from a cycle peak of 14.25% to 9.25%.

Top Zacks #1 Rank (STRONG BUY) Stocks—

Facebook ( NASDAQ: (FB - Free Report) Free Report ): This is now an incredible $476 billion in market cap stock. The long-term Zacks VGM score is a solid B, but it comes by mixing a lousy D in Value with an A in Growth. How long can that Momentum trade last?

Air Liquide ( OTCMKTS: (AIQUY - Free Report) Free Report): This is a big French Diversified Chemicals firm, with $48 billion in market cap. The Zacks long-term VGM score is a mediocre C. But the chemical industry has been red hot this year, and this is a European trading stock, another strong Momentum trade this year.

Intuitive Surgical ( NASDAQ: (ISRG - Free Report) Free Report): This is the darling of Medical-Instrument stocks, and you won’t get it cheap. The stock price is a shocking $927. This $34 billion market cap stock is indeed accruing a well-deserved Zacks Value score of F. The Zacks Growth score is C. That’s not as good as one might hope for here.

Maybe just watch these hot Momentum stocks trade, and don’t buy?

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.

Get the full Report on FB - FREE

Get the full Report on AIQUY – FREE

Get the full Report on ISRG - FREE

Follow us on Twitter:

Join us on Facebook:

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.

This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit

for information about the performance numbers displayed in this press release.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Facebook, Inc. (FB) - free report >>

Air Liquide (AIQUY) - free report >>

Intuitive Surgical, Inc. (ISRG) - free report >>

More from Zacks Press Releases

You May Like